Levobupivacaine (rINN) /liːvoʊbjuːˈpɪvəkeɪn/ is a local anaesthetic drug
belonging to the amino amide group. It is the S-enantiomer of bupivacaine.
Absorption, The plasma concentration of levobupivacaine following therapeutic
administration depends on dose and also on route of administration, because ...
In recent years levobupivacaine, the pure S (−)-enantiomer of bupivacaine,
emerged as a safer alternative for regional anesthesia than its racemic parent.
The majority of in vitro, in vivo and human pharmacodynamic studies of nerve
block indicate that levobupivacaine has similar potency to bupivacaine. However
Levobupivacaine is an amino-amide local anaesthetic drug belonging to the
family of n-alkylsubstituted. pipecoloxylidide. It is the S-enantiomer of
Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):247-68. Bupivacaine,
levobupivacaine and ropivacaine: are they clinically different? Casati A(1), Putzu
Oct 1, 2013 ... Levobupivacaine, the pure S (−)-enantiomer of bupivacaine, has strongly
emerged as a safer alternative for regional anesthesia than its ...
Aug 7, 2015 ... Levobupivacaine should be administered only by, or under the supervision of, a
clinician having the necessary training and experience.
Mann and colleagues used 7.5–10 mg of bupivacaine 0.25%, and the identical
volumes of levobupivacaine. In the bupivacaine group, a satisfactory sensory ...
LEVOBUPIVACAINE : British National Formulary provided by NICE.